查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1918132

血液透析及腹膜透析市场－2026-2031年预测

Hemodialysis and Peritoneal Dialysis Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 152 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计血液透析和腹膜透析市场将从 2025 年的 1,205.45 亿美元增长到 2031 年的 1,767.49 亿美元，复合年增长率为 6.59%。

由于肾臟疾病的增加、技术的进步以及医疗服务模式的变革，血液透析和腹膜透析市场正在快速扩张。当肾臟无法清除血液中的毒素时，就需要进行透析治疗。透析包括血液透析和腹膜透析。血液透析是一种常见的血液净化方法，患者每週需在透析中心透过手臂进行三到五次透析；腹膜透析则是一种持续的居家透析方法，患者每天透过腹部进行腹膜腔的清洁。慢性疾病的流行、生活方式因素和技术创新之间的协同作用正在推动市场成长。

主要市场驱动因素

肾臟疾病负担与风险因素

肾臟疾病的激增以及人们日益增长的担忧正在推动该行业的成长，因为肾移植需要进行大规模手术、与捐赠者进行配型，并且需要终身服用免疫抑制剂以防止器官排斥。慢性病和文明病（包括肥胖、糖尿病和高血压）的发病率上升也进一步推动了全球市场的扩张。

截至2021年，糖尿病成人患者人数最多的地区是西太平洋地区（1.67亿）、南亚地区（8,800万）和欧洲（5,900万）。随着糖尿病发生率的上升，末期肾功能衰竭（ESRD）病例也增加。此外，营养不良、不健康的生活方式和缺乏运动也是导致肾臟疾病的因素。 60%的健康问题都与生活方式因素有关，包括营养不良、吸烟、饮食不当、药物滥用、压力和饮酒。由于这些因素，全球范围内的ESRD病例都在增加，从而对透析解决方案产生了持续的需求。

消费品市场趋势

在整个预测期内，各国政府预计将在病人安全、以病人为中心的照护和改善治疗效果方面投入大量资金。企业正在生产由复合材料製成的导管，这些材料能够耐受过氧化物、碘和酒精等化学物质的侵蚀。透析器的新製造技术（改善表面接触和截留膜性能以提高扩散效率）正在积极推动耗材的扩张，进而促进血液透析和腹膜透析市场的成长。耗材市场涵盖血管、浓缩液、导管及相关产品，为製造商提供了重要的经常性商机。

住院透析的优势

由于医院拥有大量训练有素、经验丰富的医护人员，院内透析的优势预计在未来几年内仍将保持强劲。透析中心和医院等医疗机构中合格且技术精湛的肾臟护理团队能够确保最佳治疗效果并改善透析结果。多种因素预计将推动市场成长，包括竞争对手专注于建立独立的透析中心以及患者对院内透析的接受度不断提高。各公司正致力于开发具有多种介入功能的客製化血液透析机，以满足特定患者群体和临床场景的需求。

技术进步

影响市场成长的关键因素包括透析机技术的进步以及公众对透析治疗益处的日益了解。便携性、易用性和可靠性等性能提升的血液透析机需求旺盛。居家血液透析技术的广泛应用提高了患者满意度，并赋予患者更大的独立性。腹膜透析因其经济实惠且无需专用设备即可在家中进行，正日益受到患者的青睐。此外，自动化腹膜透析机的广泛应用有望推动市场成长，因为它能够实现夜间治疗，最大限度地减少对日常生活的干扰。

法规环境

全球政府监管力度的加强正透过统一的品质标准推动市场成长。血液透析和腹膜透析服务提供者必须遵守美国医疗保险和医疗补助服务中心 (CMS) 制定的品质标准。美国食品药物管理局(FDA) 对医疗设备的品质、安全性、有效性和标籤制定了相关要求。在欧盟销售的医疗设备必须通过多项测试，以确保其符合欧盟医疗设备指令的品质和安全要求。在日本，医疗器材必须符合厚生劳动省的法规。中国已颁布一部符合国际和国内标准的医疗设备法，并在主要市场建立了统一的品质标准。

区域趋势

在北美市场主导地位

北美血液透析和腹膜透析市场正蓬勃发展，这得益于知名製造商的存在、政府对先进医疗设备研发的大量投入以及完善的报销体系。随着肾衰竭和慢性肾臟病的日益增多，透析的普及率也不断提高。医疗保健成本的上涨、政府的扶持政策以及居民可支配收入的增加，都进一步推动了该市场的发展。

亚太地区的成长轨迹

预计亚太地区在预测期内将占据显着的市场份额。先进产品的不断发展、老龄化人口的不断扩大以及肾衰竭发病率的上升预计将推动市场成长。根据国际糖尿病联盟（IDF）估计，东南亚已有8,800万人患有慢性肾臟病，预计到2045年这数字将达到1.53亿人。政府主导的增加、慢性肾臟病（CKD）意识提升计画的发展、技术先进的产品以及新建的现代化医疗设施都在影响市场成长。

血液透析和腹膜透析市场在技术进步、慢性病负担加重以及医疗服务可近性提高的推动下不断发展。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2021-2025 年）和预测资料（2026-2031 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 血液透析/腹膜透析市场：依类型划分

  • 介绍
  • 血液透析
  • 腹膜透析

第六章 按产品分類的血液透析和腹膜透析市场

  • 介绍
  • 医疗设备
  • 消耗品

7. 按最终用户分類的血液透析和腹膜透析市场

  • 介绍
  • 居家医疗
  • 医院

第八章 按地区分類的血液透析和腹膜透析市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • The Renal Project
  • DaVita
  • Fresenius Kidney Care
  • NephroPlus
  • NxStage
  • Mayo Clinic
  • NephCure
  • Fresenius
  • Cleveland Clinic

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615918

The hemodialysis and peritoneal dialysis market is expected to expand at a 6.59% CAGR, reaching USD 176.749 billion in 2031 from USD 120.545 billion in 2025.

The hemodialysis and peritoneal dialysis market is expanding rapidly driven by rising kidney-related illnesses, technological advancements, and evolving healthcare delivery models. Dialysis procedures-performed when kidneys cannot remove toxins from blood-encompass hemodialysis, a common blood cleaning procedure conducted at dialysis centers three to five times weekly through arm access, and peritoneal dialysis, a continuous home-based procedure that cleans the peritoneal cavity in the abdomen daily through abdominal access. The convergence of chronic disease prevalence, lifestyle factors, and technological innovation is propelling market growth.

Primary Market Drivers

Kidney Disease Burden and Risk Factors

Industry growth is attributed to surging kidney-related illnesses and concerns, as kidney transplantation requires major procedures, donor matching, and lifetime immunosuppressant medication regimens to prevent organ rejection. The rising incidence of chronic diseases and lifestyle-related illnesses including obesity, diabetes, and hypertension further supports worldwide market expansion.

In 2021, adults living with diabetes were most prevalent in the Western Pacific (167 million), South Asia (88 million), and Europe (59 million). End-stage renal disease cases are rising in correlation with increasing diabetes incidence. Additionally, kidney problems result from poor nutrition, unhealthy lifestyles, and lack of physical activity. Lifestyle factors are responsible for 60% of health-related issues, including malnutrition, smoking, improper diet, drug misuse, stress, and alcohol consumption. These variables are causing ESRD instances to increase internationally, creating sustained demand for dialysis solutions.

Consumables Market Evolution

Throughout the projection period, governments are anticipated to make substantial expenditures improving patient safety, patient-centered treatment, and efficacy. Companies are producing catheters composed of complex materials impervious to chemicals like peroxides, iodine, and alcohol. New production techniques for dialyzers-featuring better surface contact and cutoff membrane properties for higher diffusion-positively affect consumables expansion, driving hemodialysis and peritoneal dialysis market growth. The consumables market encompasses bloodlines, concentrates, catheters, and related items, representing significant recurring revenue opportunities for manufacturers.

Hospital-Based Dialysis Dominance

Hospital-based dialysis dominance is projected to remain strong in upcoming years due to substantial availability of highly trained, experienced healthcare workers in hospital settings. In healthcare environments like dialysis centers and hospitals, qualified and skilled renal care teams guarantee optimal care and improved dialysis outcomes. Various factors-including competitors' increased focus on creating independent dialysis facilities and patients' growing acceptance of in-center dialysis-are projected to drive market growth. Companies are focusing on developing customized hemodialysis equipment with diverse interventions, addressing specific patient population needs and clinical scenarios.

Technological Advancement

Major factors influencing market growth include technological advancements in dialysis equipment and growing public awareness of treatment benefits. Hemodialysis machines with improved characteristics including portability, usability, and dependability are experiencing high demand. Hemodialysis technology availability for home use has increased patient satisfaction and offered greater independence. Peritoneal dialysis is gaining popularity as a cost-effective and practical alternative for patients, capable of being performed at home without specialized equipment. Additionally, automated peritoneal dialysis equipment availability is likely to fuel market growth, enabling overnight treatments that minimize lifestyle disruption.

Regulatory Environment

Government regulations have been increasing globally, fueling market growth through quality standardization. Hemodialysis and peritoneal dialysis service providers must adhere to quality standards set by the Centres for Medicare & Medicaid Services. The FDA establishes requirements for medical devices regarding quality, safety, efficacy, and labeling. Before marketing in the European Union, medical devices must pass multiple tests guaranteeing quality and safety under the EU Medical Device Directive. In Japan, equipment must adhere to Ministry of Health, Labour, and Welfare regulations. China has enacted medical device laws following international and domestic standards, creating harmonized quality expectations across major markets.

Regional Dynamics

North American Market Leadership

The North American hemodialysis and peritoneal dialysis market is growing due to well-known manufacturers' presence, major government expenditures in cutting-edge medical device development, and supportive reimbursement frameworks. Dialysis prevalence is rising due to increasing kidney failures and Chronic Kidney Disease. Increasing healthcare spending, government initiatives, and high disposable income further promote market development.

Asia Pacific Growth Trajectory

The Asia Pacific region is anticipated to hold significant market share during the projected period. Increased development of cutting-edge products, expanding elderly populations, and rising renal failure occurrences are predicted to promote market growth. The IDF estimates 88 million individuals in Southeast Asia already have diabetes, with 153 million likely to have the disease by 2045. Increased government initiatives, CKD awareness programs, technologically advanced products, and recently built state-of-the-art healthcare facilities are influencing market growth.

Recent Developments

In April 2023, AWAK Technologies and Singapore General Hospital initiated a pre-pivotal clinical investigation of a wearable peritoneal dialysis device. Also in April 2023, Tablo received FDA approval for usage in various locations including home and hospital settings, featuring user-friendly interactive touchscreens with 3-D graphics and conversational instructions. In February 2023, the first central government building for hemodialysis was fitted with online hemodiafiltration machines and inaugurated at Safdarjung Hospital in New Delhi, India.

The hemodialysis and peritoneal dialysis market continues evolving, driven by technological sophistication, chronic disease burden, and healthcare accessibility improvements.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Hemodialysis and Peritoneal Dialysis Market Segmentation

  • By Type
  • Hemodialysis
  • Peritoneal dialysis
  • By Product
  • Device
  • Consumables
  • By End-User
  • Home-based
  • Hospital-based
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Hemodialysis
  • 5.3. Peritoneal dialysis

6. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Device
  • 6.3. Consumables

7. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Home-based
  • 7.3. Hospital-based

8. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. The Renal Project
  • 10.2. DaVita
  • 10.3. Fresenius Kidney Care
  • 10.4. NephroPlus
  • 10.5. NxStage
  • 10.6. Mayo Clinic
  • 10.7. NephCure
  • 10.8. Fresenius
  • 10.9. Cleveland Clinic

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations